TAOX Form 4: Director awarded 10,000 stock options at $10.38

Rhea-AI Filing Summary

TAO Synergies Inc. (TAOX) filed a Form 4 reporting a director’s equity award. The reporting person received an employee stock option grant for 10,000 shares at an exercise price of $10.38 per share. The options become exercisable on July 14, 2026 and expire on July 14, 2035.

The grant was approved on July 14, 2025, subject to shareholder approval of an increase to the 2020 Equity Incentive Plan; shareholders approved the amendment on August 6, 2025. Following the transaction, 10,000 derivative securities were beneficially owned on a direct basis.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SCHECHTER JONATHAN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	10,000	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 10,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHECHTER JONATHAN

(Last) (First) (Middle)

C/O TAO SYNERGIES INC.

1185 AVENUE OF THE AMERICAS, 3RD FLOOR

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TAO Synergies Inc. [ TAOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$10.38	08/06/2025(1)		A		10,000		07/14/2026	07/14/2035	Common Stock	10,000	$0	10,000	D

Explanation of Responses:

1. The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Issuer's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Issuer received shareholder approval of the amendment to the Plan on August 6, 2025.

	/s/ Robert Weinstein, Attorney-in-fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TAO Synergies (TAOX) report on Form 4?

A director received an employee stock option grant for 10,000 shares at an exercise price of $10.38 per share.

When do the reported TAOX options become exercisable and when do they expire?

The options are exercisable on July 14, 2026 and expire on July 14, 2035.

What approvals were tied to the TAOX option grant?

The grant was approved on July 14, 2025 and was subject to shareholder approval of an amendment to the 2020 Equity Incentive Plan, which was obtained on August 6, 2025.

How many derivative securities were owned after the reported TAOX transaction?

10,000 derivative securities were beneficially owned following the transaction.

What is the ownership form for the reported TAOX options?

Ownership is reported as Direct (D).

What is the relationship of the reporting person to TAO Synergies (TAOX)?

The reporting person is a Director.